3 High-Risk Biotechs That Could Pop or Drop in 2018 Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three biotech companies that face make-or-break catalysts this year. Source: BioSpace You Might Also Like <b>Spruce Biosciences</b> Provides Corporate Update On Series A Venture Financing, Leadership Team And Lead Clinical Program October 11, 2017 Senseonics Prices $41 Million Underwritten Offering of Common Stock May 25, 2017 FDA Lashes Out at Jazz Pharma CMO for Continued Regulatory Violations January 26, 2017
<b>Spruce Biosciences</b> Provides Corporate Update On Series A Venture Financing, Leadership Team And Lead Clinical Program October 11, 2017
